RE: Pablo4 Feb 2019 22:48
The performance shares already issued are included in the 1,419 Million Calidus shares, but are in escrow until June (23rd I think), as are the original shares issued to Keras when the original deal was done.
Together they make up 32.3% of the 1,419 million = 458,337,000.
So I make it that leaves almost 1,000 million shares currently “in circulation” which can be traded.
Performance shares for Keras on a positive PFS are 275 million, which will also be escrowed until June, assuming they’re issued before.
There would then be 1,694 million Calidus shares , of which 733,337,000 held by Keras.
I really hope, expect even, that Keras will ask all shareholders prior to the in specie distribution whether they wish to retain their Calidus shares, or to sell them, or perhaps a mix - sell some, keep some, and that they might find an investor(s) (Alkane?) for those that shareholders wish to sell, so that there aren’t suddenly loads of shares available on the market.
With many investors having Keras shares held in ISA & SIPP accounts, and thus protected from CGT, some with brokers who currently cannot trade ASX shares there is plenty of thinking & planning ahead for us all. But however keen we are to plan ahead we just have to wait for the PFS & of course the gold price to keep steadily rising!
All IMO & open to correction, as worked out at 10.45 pm!